AMETEK (NYSE:AME) Posts Earnings Results, Beats Expectations By $0.07 EPS

AMETEK (NYSE:AME) issued its earnings results on Tuesday. The technology company reported $2.01 EPS for the quarter, topping the consensus estimate of $1.94 by $0.07, Briefing.com reports. The company had revenue of $2 billion during the quarter, compared to the consensus estimate of $1.94 billion. AMETEK had a return on equity of 16.55% and a net margin of 20.00%.The firm’s revenue for the quarter was up 13.4% compared to the same quarter last year. During the same period in the previous year, the company posted $1.87 EPS. AMETEK updated its Q1 2026 guidance to 1.850-1.900 EPS and its FY 2026 guidance to 7.870-8.070 EPS.

Here are the key takeaways from AMETEK’s conference call:

• Record results: AMETEK closed Q4 with record sales and orders (Q4 sales $2.0B, +13%; orders +18%) and a record backlog of $3.58B, while full‑year sales were $7.4B and diluted EPS was $7.43 (+9%).
• Margins and cash flow strength: Core margins expanded (Q4 core margin 27.6%, +100 bps), operating margin 26.2%, EBITDA margin 30.9%, and Q4 free cash flow was a record $527M with FCF conversion of 132% (2025 FCF conversion 113%).
• Active M&A and capital capacity: Management closed FARO and Kern in 2025, announced the LKC Technologies ophthalmic deal, and says it can deploy >$5B of capital while maintaining investment‑grade credit, prioritizing acquisitions alongside buybacks and dividends.
• 2026 guidance: Management expects overall sales up mid‑ to high‑single digits, organic sales up low‑ to mid‑single digits, and diluted EPS of $7.87–$8.07 (up 6–9%); Q1 sales are guided ~+10% with adjusted EPS $1.90–$1.95.
• Near‑term headwinds and execution risks include margin dilution from lower‑margin acquisitions (FARO mid‑teens EBITDA today), integration/one‑time charges (~$17.6M disclosed), higher 2026 D&A (approx. $430M including ~$210M acquisition‑related), and an expected higher effective tax rate (18.5–19.5%).

AMETEK Trading Up 0.8%

Shares of AMETEK stock traded up $1.86 on Thursday, hitting $229.69. The stock had a trading volume of 212,667 shares, compared to its average volume of 1,382,489. The stock has a 50 day moving average of $209.65 and a 200 day moving average of $195.06. The company has a debt-to-equity ratio of 0.10, a quick ratio of 0.72 and a current ratio of 1.06. AMETEK has a twelve month low of $145.02 and a twelve month high of $234.56. The firm has a market capitalization of $52.88 billion, a P/E ratio of 35.92, a PEG ratio of 3.10 and a beta of 1.03.

AMETEK Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 19th. Stockholders of record on Friday, December 5th were paid a $0.31 dividend. The ex-dividend date of this dividend was Friday, December 5th. This represents a $1.24 annualized dividend and a dividend yield of 0.5%. AMETEK’s dividend payout ratio is currently 19.56%.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on AME shares. Weiss Ratings reissued a “buy (b)” rating on shares of AMETEK in a research report on Wednesday, January 21st. Mizuho set a $235.00 price objective on shares of AMETEK in a report on Wednesday. Morgan Stanley raised their target price on shares of AMETEK from $198.00 to $215.00 and gave the stock an “equal weight” rating in a report on Monday, January 12th. Deutsche Bank Aktiengesellschaft started coverage on AMETEK in a research note on Wednesday, January 21st. They issued a “buy” rating and a $271.00 price target for the company. Finally, KeyCorp increased their target price on AMETEK from $235.00 to $260.00 and gave the stock an “overweight” rating in a report on Wednesday. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, AMETEK currently has an average rating of “Moderate Buy” and an average price target of $243.00.

AMETEK News Roundup

Here are the key news stories impacting AMETEK this week:

• Positive Sentiment: Q4 results beat expectations — EPS and revenue topped estimates; revenue rose ~13% YoY, driving the record‑year narrative and underpinning near‑term momentum. AMETEK Q4 Earnings Surpass Expectations, Revenues Rise Y/Y
• Positive Sentiment: Company and management framed 2025 as a record year and gave a confident 2026 outlook (but with specific guidance ranges investors can model). This supports continued revenue and margin trajectory assumptions. AMETEK (AME) Earnings Call Highlights Record Year
• Positive Sentiment: Strategic M&A: AMETEK acquired LKC Technologies and is pushing into ophthalmic technology — this expands addressable markets and was highlighted as a growth vector by analysts. AMETEK Eyes Growth In Ophthalmic Tech While Valuation Stays Premium
• Positive Sentiment: Analyst support: KeyCorp raised its price target to $260 (overweight) and DA Davidson reaffirmed a buy at $240 — analyst upgrades/raises add buying interest and validate outperformance expectations. Analyst Notes (KeyCorp / DA Davidson)
• Neutral Sentiment: Detailed call and transcripts are available for investors; management reiterated strategy (organic growth + M&A) and provided guidance ranges that require modeling vs. consensus. AMETEK Q4 2025 earnings call transcript
• Neutral Sentiment: Analyst divergence: while some firms raised targets, others remain cautious — watch how guidance compares to consensus in coming sessions. Resilient Revenue and Margin Caution Keep Ametek at Hold
• Negative Sentiment: Valuation concerns — some commentary argues AMETEK’s premium multiple may be a constraint and could lead to downgrades if growth slows. That raises downside risk despite strong fundamentals. AMETEK: Perilously Close To A Downgrade As Valuation Outweighs Fantastic Growth
• Negative Sentiment: Tariff uncertainty and margin pressure: management noted potential headwinds from tariffs and cautioned that 2026 profit could come in below some estimates — a risk to near‑term EPS. AMETEK forecasts 2026 profit below estimates on tariff uncertainty

Insider Buying and Selling at AMETEK

In other news, CEO David A. Zapico sold 88,000 shares of the stock in a transaction dated Tuesday, November 25th. The stock was sold at an average price of $196.39, for a total value of $17,282,320.00. Following the completion of the sale, the chief executive officer owned 348,955 shares of the company’s stock, valued at approximately $68,531,272.45. This represents a 20.14% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Thomas C. Marecic sold 14,310 shares of the firm’s stock in a transaction dated Monday, December 15th. The stock was sold at an average price of $202.11, for a total value of $2,892,194.10. Following the transaction, the insider owned 42,589 shares of the company’s stock, valued at $8,607,662.79. This trade represents a 25.15% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 137,088 shares of company stock worth $27,212,340. 0.57% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On AMETEK

A number of large investors have recently bought and sold shares of the stock. CIBC Bancorp USA Inc. bought a new stake in AMETEK in the 3rd quarter valued at about $5,990,000. Advisory Services Network LLC bought a new position in AMETEK in the third quarter worth approximately $92,000. Morningstar Investment Management LLC bought a new position in shares of AMETEK in the 3rd quarter worth $925,000. NewEdge Advisors LLC grew its holdings in shares of AMETEK by 12.8% during the third quarter. NewEdge Advisors LLC now owns 4,451 shares of the technology company’s stock valued at $837,000 after buying an additional 505 shares during the last quarter. Finally, CANADA LIFE ASSURANCE Co raised its holdings in shares of AMETEK by 3.3% in the 3rd quarter. CANADA LIFE ASSURANCE Co now owns 351,093 shares of the technology company’s stock worth $65,585,000 after acquiring an additional 11,235 shares during the last quarter. 87.43% of the stock is currently owned by institutional investors and hedge funds.

About AMETEK

AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.

The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.